Ignite Creation Date:
2024-05-06 @ 1:39 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01860157
Status:
COMPLETED
Last Update Posted:
2017-05-31
First Post:
2013-05-18
Brief Title:
Deep rTMS for Treatment-Resistant Late-life Depression
Sponsor:
Centre for Addiction and Mental Health
Organization:
Centre for Addiction and Mental Health
Study Overview
Official Title:
A Randomized Controlled Study of H1-Coil rTMS for Treatment-Resistant Late-Life Depression
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
rTMS
Brief Summary:
In this study the investigators will be examining the effects of the deep repetitive transcranial magnetic stimulation rTMS using the H1 coil in patients over the age of 60 who have been unable to tolerate or failed to respond to antidepressant medications The coil was designed to stimulate deeper regions of the left DLPFC The investigators propose that active stimulation with the H1 coil will result in higher remission rates than placebo stimulation but will have a similar tolerability and safety profile
Detailed Description:
This study is a randomized double blind sham controlled study to evaluate the safety and efficacy of H1-coil rTMS as a treatment for patients over 60 years of age with major depressive disorder who have not tolerated or failed to respond to antidepressant medications The study duration is 4-6 weeks in length The acute phase is 4 weeks of 5 daily treatments followed by 2 weeks of biweekly treatment if remission is achieved at the 4 week mark Symptom change and remission criteria will be assessed using the HRDS-24 item Cognition will be assessed using a validated battery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None